SYNLAB AG (SYAB.F)

12.40 -0.23 (-1.82%) 市場開市。 截至 08:03AM CEST。

SYNLAB AG

Moosacher Straße 88
Munich 80809
Germany
49 89 307602 0
https://www.synlab.com

版塊: Healthcare
行業: Diagnostics & Research
全職員工: 30,000

高階主管

名稱	標題	支付	行使價	出生年份
Mr. Mathieu Floreani	Chief Exec. Officer	無	無	1968
Dr. Bartholomäus Wimmer	Founder & Independent Member of the Supervisory Board	無	無	1961
Mr. Sami Badarani	Chief Financial Officer	無	無	1963
Mr. Robert Steinwander	Chief Operating Officer	無	無	無
Mr. Henrik Andreasen	Chief Information Officer	無	無	無
Fabian Walla	Group Gen. Counsel	無	無	無
Ms. Catharina Monster	Chief HR Officer	無	無	無
Mr. Luis Vieira	Chief Strategy Officer	無	無	無
Dr. Santiago Valor	Chief Medical Officer	無	無	無
Christoph Mahnke	CEO of SYNLAB Germany	無	無	無

截止 為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 EUR。

描述

SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 500 laboratories and 1,800 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.

公司管治

截至 無 止，SYNLAB AG 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。